Early Phase 1 Castration-resistant Prostate Cancer Clinical Trials
4 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–4 of 4 trials
Recruiting
Early Phase 1
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Allogeneic CAR-NK Cell Therapy for Metastatic Castration-resistant Prostate Cancer (mCRPC)
Prostate Cancer Castration-resistant Prostate Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences15 enrolled1 locationNCT07298239
Recruiting
Early Phase 1
Study of Allogeneic Anti-PSMA CAR-NK Cell for Metastatic Castration-Resistant Prostate Cancer
Prostate Cancer Castration-resistant Prostate Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences10 enrolled1 locationNCT07156045
Recruiting
Early Phase 1
177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Peking Union Medical College Hospital30 enrolled1 locationNCT05603559
Recruiting
Early Phase 1
Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC
Metastatic Castration-resistant Prostate CancerCastration-resistant Prostate Cancer
Shanghai Changzheng Hospital18 enrolled1 locationNCT06228404